Answers are grounded in this paper and cite their sources.
Sensory reactivity differences are experienced by between 5 and 15% of the population. This often takes the form of sensory over-responsivity (SOR), in which sensory stimuli are experienced as unusually intense and everyday function is affected. A potential mechanism underlying over-responsivity is an imbalance between neural excitation and inhibition in which inhibitory influences are relatively weakened. Therefore, interventions that boost neural inhibition or reduce neural excitation may reduce SOR. Vitamin-B6 is the coenzyme for conversion of excitatory glutamate to inhibitory GABA, and in animal models it both increases the concentration of GABA and reduces glutamate. To test whether Vitamin-B6 reduces SOR, we recruited 300 adults from the general population who completed the Sensory Processing 3-Dimensions Scale (SP-3D) first at baseline, and again following randomisation to either one month’s supplementation with 100 mg Vitamin-B6, or one of two control conditions (1000 µg Vitamin-B12 or placebo). To focus on individuals who experience sensory over-responsivity, we analysed the effects of supplementation only on individuals with high baseline SOR scores (above the 87th percentile). In this group, Vitamin-B6 selectively reduced SOR compared to both placebo and Vitamin-B12. Clinical trials and mechanistic studies should now be conducted in autism, ADHD, and other groups with SOR.
No takes yet. Share an insight, caveat, or question.
Field et al. (2023) studied this question.